Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina

Grujić-Vujmilović, Dragana (avtor), Veljković, Kristina (avtor), Gavrić, Živana (avtor), Popović-Pejičić, Snježana (avtor)

The Republic of Srpska (RS), as a part of the Western Balkans (WB) region, has a higher diabetes prevalence than the EU. This study aims to assess the cost-effectiveness of early treatment of high-risk patients with pre-diabetes and undiagnosed diabetes in our setting. We designed a Markov chain Monte Carlo (MCMC) model which reflects the current International Diabetes Federation (IDF) three-step plan for the prevention of T2DM in those at increased risk. The model captures the evolution of the disease in FINDRISC high-risk patients from normal glucose tolerance (NGT) to impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) and then to T2DM and its complications. We developed two MCMC models, in order to follow the progression of the disease in high-risk cases, ie, when early treatment is undertaken or when it is not undertaken. The health costs and quality adjusted life years (QALY) were discounted at an annual rate of 3%. The key model parameters were varied in one-way and probabilistic sensitivity analysis. Early treatment resulted in increased life expectancy, postponement of the onset of diabetes and increased QALY for all patients. The discounted incremental cost-effectiveness-ratios (ICER) in NGT, IFG, IGT, and T2DM patients were −289.9, 9724.03, −1478.59 and 4084.67 €. In high-risk IGT patients, ICER was the most favorable, being both a cost saving and QALY gaining, with the consistent results confirmed by the sensitivity analysis. The results recommend the acceptance of a new health policy of identifying IGT patients with the use of FINDRISC questionnaire and plasma glucose measurements; providing them with a lifestyle change program; and implementing intensive diabetes treatment, as their disease progresses. Our results are especially significant for the Western Balkan countries, since this was the first cost-effectiveness study of T2DM prevention in this region.

• Jezik: Angleški jezik
• Ključne besede: cost-effectiveness, Markov chain model, FINDRISC, prevention, impaired glucose tolerance, type 2 diabetes mellitus
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.01 - Izvirni znanstveni članek
• Organizacija: FRI - Fakulteta za računalništvo in informatiko
• Status publikacije: Objavljeno
• Različica publikacije: Objavljena publikacija
• Leto izida: 2025
• Št. strani: 18 str.
• Številčenje: Vol. 20, iss. 1, art. 2437226
• PID: 20.500.12556/RUL-166073
• UDK: 519.217.2:616.379-008.64
• ISSN pri članku: 1993-2820
• DOI: 10.1080/19932820.2024.2437226
• COBISS.SI-ID: 219780867
• Datum objave v RUL: 19.12.2024

GRUJIĆ-VUJMILOVIĆ, Dragana, VELJKOVIĆ, Kristina, GAVRIĆ, Živana in POPOVIĆ-PEJIČIĆ, Snježana, 2025, Cost-effectiveness of prevention program for type 2 diabetes mellitus in high risk patients in the Republic of Srpska, Bosnia and Herzegovina. Libyan journal of medicine [na spletu]. 2025. Vol. 20, no. 1,  2437226. [Dostopano 4 maj 2025]. DOI 10.1080/19932820.2024.2437226. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=166073

Gradivo je del revije

• Naslov: Libyan journal of medicine
• Skrajšan naslov: Libyan j. med.
• Založnik: Taylor & Francis
• ISSN: 1993-2820
• COBISS.SI-ID: 517571097

Licence

• Licenca: CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by-nc/4.0/deed.sl
• Opis: Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: stroškovna učinkovitost, model Markovskih verig, FINDRISC, preventiva, oslabljena glukozna toleranca, sladkorna bolezen tipa 2